Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04620278 · ClinicalTrials.gov registry record
Genetic Investigation of Cancer Predisposition
A clinical trial, sponsored by The University of Texas Health Science Center at San Antonio.
- Not yet
- Registry status
- 100
- Enrollment target
NCT04620278 is a clinical trial that has not yet begun recruiting, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 100 participants.
The verdict
NCT04620278 has not yet begun recruiting, sponsored by The University of Texas Health Science Center at San Antonio.
- NOT YET RECRUITING
- Registry status
- 100 participants
- Enrollment target
Study Summary
Clinical information and samples (blood, saliva, and tumor) will be collected from patients with multiple cancers and/or a family history of cancer as well as from affected and unaffected relatives; samples will be systematically sequenced and evaluated for candidate driver mutations.
Interventions
- GENETIC DNA or RNA Sequencing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-10 |
| Est. Completion | 2035-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04620278
The ClinicalTrials.gov registry entry for NCT04620278 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DNA or RNA Sequencing is the first listed.
NCT04620278 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04620278 about?
NCT04620278 is a clinical study titled "Genetic Investigation of Cancer Predisposition". Clinical information and samples (blood, saliva, and tumor) will be collected from patients with multiple cancers and/or a family history of cancer as well as from affected and unaffected relatives; samples will be systematically sequenced and evaluated for candidate driver mutations.
What is the current status of trial NCT04620278?
This trial is currently not yet recruiting. The enrollment target is 100 participants. The study started on 2026-10. Estimated completion is 2035-12.
What interventions are being tested in trial NCT04620278?
The interventions under investigation include: DNA or RNA Sequencing (GENETIC).
Who is sponsoring clinical trial NCT04620278?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.